VICEOLIS
Dead / Abandoned — Abandoned — failure to respond (as of 24 Jan 2023)
What this means for you
This application is over — abandoned 03 Jan 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79327762
- Mark type
- Stylized text
- Filed
- 03 Nov 2021
- Abandoned
- 03 Jan 2023
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals and medical preparations for human use; pharmaceutical preparations within the fields of pulmonary diseases, cardiovascular diseases, autoimmune and inflammatory diseases, fibrotic diseases and kidney diseases; pharmaceutical preparations for pulmonary fibrosis, namely, ipf; pharmaceutical preparations for diffuse systemic sclerosis (lung manifestations); pharmaceutical preparations for infectious lung diseases; pharmaceutical preparations for covid-19
Owner
- Vicore Pharma AB, XP
Prosecution history
- 14 Feb 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 24 Jan 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 24 Jan 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 22 Oct 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 29 May 2023 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 10 May 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 10 May 2023 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 25 Jan 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 24 Jan 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 24 Jan 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 26 Jul 2022 — REFUSAL PROCESSED BY IB
- 01 Jul 2022 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 01 Jul 2022 — REFUSAL PROCESSED BY MPU
- 29 Jun 2022 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 28 Jun 2022 — NON-FINAL ACTION WRITTEN